Cyclodextrin-Modified CeO₂ Nanoparticles as a Multifunctional Nanozyme for Combinational Therapy of Psoriasis

References

• Griffiths CEM, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263–271. doi:10.1016/S0140-6736(07)61128-317658397
   PubMed Web of Science ®Google Scholar
• Papp KA, Reich K, Paul C, et al. A prospective Phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis. Br J Dermatol. 2016;175(2):273–286. doi:10.1111/bjd.1449326914406
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol. 2004;51(5):704–708. doi:10.1016/j.jaad.2004.04.01415523347
   PubMed Web of Science ®Google Scholar
• Strober BE, van der Walt JM, Armstrong AW, et al. Clinical goals and barriers to effective psoriasis care. Dermatol Ther. 2019;9(1):5–18. doi:10.1007/s13555-018-0279-5
   PubMed Web of Science ®Google Scholar
• Eberle F, Brück J, Holstein J, Hirahara K, Ghoreschi K. Recent advances in understanding psoriasis. F1000Res. 2016;5(770).
   PubMedGoogle Scholar
• Reindl J, Pesek J, Krüger T, et al. Proteomic biomarkers for psoriasis and psoriasis arthritis. J Proteomics. 2016;140:55–61. doi:10.1016/j.jprot.2016.03.04027063990
   PubMed Web of Science ®Google Scholar
• Seth D, Ehlert AN, Golden JB, et al. Interaction of resistin and systolic blood pressure in psoriasis severity. J Invest Dermatol. 2019;19:33401–33403.
   Google Scholar
• Conic RR, Damiani G, Schrom KP, et al. Psoriasis and psoriatic arthritis cardiovascular disease endotypes identified by red blood cell distribution width and mean platelet volume. J Clin Med. 2020;9(1):186. doi:10.3390/jcm9010186
   PubMed Web of Science ®Google Scholar
• Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of Psoriasis. Annu Rev Immunol. 2014;32:227–255. doi:10.1146/annurev-immunol-032713-12022524655295
   PubMed Web of Science ®Google Scholar
• Utaş S, Köse K, Yazici C, Akdaş A, Keleştimur F. Antioxidant potential of propylthiouracil in patients with psoriasis. Clin Biochem. 2002;35(3):241–246. doi:10.1016/S0009-9120(02)00294-112074833
   PubMed Web of Science ®Google Scholar
• Yildirim M, Inaloz H, Baysal V, Delibas N. The role of oxidants and antioxidants in psoriasis. F1000Research. 2003;17(1):34–36.
   Google Scholar
• Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive Oxygen Species in Inflammation and Tissue Injury. Antioxid Redox Signal. 2014;20(7):1126–1167. doi:10.1089/ars.2012.514923991888
   PubMed Web of Science ®Google Scholar
• Zhou Q, Mrowietz U, Rostami-Yazdi M. Oxidative stress in the pathogenesis of psoriasis. Free Radical Biol Med. 2009;47(7):891–905. doi:10.1016/j.freeradbiomed.2009.06.03319577640
   PubMed Web of Science ®Google Scholar
• Lin X, Huang T. Oxidative stress in psoriasis and potential therapeutic use of antioxidants. Free Radic Res. 2016;50(6):585–595. doi:10.3109/10715762.2016.116230127098416
   PubMed Web of Science ®Google Scholar
• Zhang S, Liu X, Mei L, Wang H, Fang F. Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB/c mice. BMC Complement Altern Med. 2016;16(1):334. doi:10.1186/s12906-016-1325-427581210
   PubMedGoogle Scholar
• Li P, Li Y, Jiang H, et al. Glabridin, an isoflavan from licorice root, ameliorates imiquimod-induced psoriasis-like inflammation of BALB/c mice. Int Immunopharmacol. 2018;59:243–251. doi:10.1016/j.intimp.2018.04.01829665498
   PubMed Web of Science ®Google Scholar
• Lai R, Xian D, Xiong X, Yang L, Song J, Zhong J. Proanthocyanidins: novel treatment for psoriasis that reduces oxidative stress and modulates Th17 and Treg cells. Redox Rep. 2018;23(1):130–135. doi:10.1080/13510002.2018.146202729630472
   PubMed Web of Science ®Google Scholar
• Simpson BS, Luo X, Costabile M, et al. Polyandric acid A, a Clerodane diterpenoid from the australian medicinal plant dodonaea polyandra, attenuates pro-inflammatory cytokine secretion in vitro and in vivo. J Nat Prod. 2014;77(1):85–91. doi:10.1021/np400704b24400858
   PubMed Web of Science ®Google Scholar
• Yang G, Li S, Yang Y, et al. Nobiletin and 5-hydroxy-6,7,8,3′,4′-pentamethoxyflavone ameliorate 12-O-tetradecanoylphorbol-13-acetate-Induced psoriasis-like mouse skin lesions by regulating the expression of Ki-67 and proliferating cell nuclear antigen and the differentiation of CD4+ T cells through mitogen-activated protein kinase signaling pathways. J Agric Food Chem. 2018;66(31):8299–8306. doi:10.1021/acs.jafc.8b0252430058806
   PubMed Web of Science ®Google Scholar
• Chen S, Han K, Li H, et al. Isogarcinol extracted from garcinia mangostana L. Ameliorates imiquimod-induced psoriasis-like skin lesions in mice. J Agric Food Chem. 2017;65(4):846–857. doi:10.1021/acs.jafc.6b0520728081600
   PubMed Web of Science ®Google Scholar
• Wei H, Wang E. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes. Chem Soc Rev. 2013;42(14):6060–6093. doi:10.1039/c3cs35486e23740388
   PubMed Web of Science ®Google Scholar
• Huang Y, Ren J, Qu X. Nanozymes: classification, catalytic mechanisms, activity regulation, and applications. Chem Rev. 2019;119(6):4357–4412. doi:10.1021/acs.chemrev.8b0067230801188
   PubMed Web of Science ®Google Scholar
• Singh N, Savanur MA, Srivastava S, D’Silva P, Mugesh G. A redox modulatory Mn3O4 nanozyme with multi-enzyme activity provides efficient cytoprotection to human cells in a parkinson’s disease model. Angew Chem Int Ed. 2017;56(45):14267–14271. doi:10.1002/anie.201708573
   PubMed Web of Science ®Google Scholar
• Kwon HJ, Cha M-Y, Kim D, et al. Mitochondria-targeting ceria nanoparticles as antioxidants for alzheimer’s disease. ACS Nano. 2016;10(2):2860–2870. doi:10.1021/acsnano.5b0804526844592
   PubMed Web of Science ®Google Scholar
• Yang X, Yang Y, Gao F, Wei -J-J, Qian C-G, Sun M-J. Biomimetic hybrid nanozymes with self-supplied H+ and accelerated O2 generation for enhanced starvation and photodynamic therapy against hypoxic tumors. Nano Lett. 2019;19(7):4334–4342. doi:10.1021/acs.nanolett.9b0093431179709
   PubMed Web of Science ®Google Scholar
• Fan L, Xu X, Zhu C, et al. Tumor catalytic–photothermal therapy with yolk–shell gold@carbon nanozymes. ACS Appl Mater Interfaces. 2018;10(5):4502–4511. doi:10.1021/acsami.7b1791629341583
   PubMed Web of Science ®Google Scholar
• Liu C, Xing J, Akakuru OU, et al. Nanozymes-engineered metal–organic frameworks for catalytic cascades-enhanced synergistic cancer therapy. Nano Lett. 2019;19(8):5674–5682. doi:10.1021/acs.nanolett.9b0225331361142
   PubMed Web of Science ®Google Scholar
• Rajkovic O, Gourmel C, d’Arcy R, et al. Reactive oxygen species-responsive nanoparticles for the treatment of ischemic stroke. Adv Ther. 2019;2(7):1900038. doi:10.1002/adtp.201900038
   Google Scholar
• Zhang K, Tu M, Gao W, et al. Hollow prussian blue nanozymes drive neuroprotection against ischemic stroke via attenuating oxidative stress, counteracting inflammation, and suppressing cell apoptosis. Nano Lett. 2019;19(5):2812–2823. doi:10.1021/acs.nanolett.8b0472930908916
   PubMed Web of Science ®Google Scholar
• Ni D, Wei H, Chen W, et al. Ceria nanoparticles meet hepatic ischemia-reperfusion injury: the perfect imperfection. Adv Mater. 2019;31(40):1902956. doi:10.1002/adma.201902956
   Web of Science ®Google Scholar
• Wang G, Zhang J, He X, Zhang Z, Zhao Y. Ceria nanoparticles as enzyme mimetics. Chin J Chem. 2017;35(6):791–800. doi:10.1002/cjoc.201600845
   Web of Science ®Google Scholar
• Nicolini V, Gambuzzi E, Malavasi G, et al. Evidence of catalase mimetic activity in Ce3+/Ce4+ doped bioactive glasses. J Phys Chem B. 2015;119(10):4009–4019. doi:10.1021/jp511737b25710332
   PubMed Web of Science ®Google Scholar
• Kim CK, Kim T, Choi I-Y, et al. Ceria nanoparticles that can protect against ischemic stroke. Angew Chem Int Ed. 2012;51(44):11039–11043. doi:10.1002/anie.201203780
   PubMed Web of Science ®Google Scholar
• Kim J, Kim HY, Song SY, et al. Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano. 2019;13(3):3206–3217. doi:10.1021/acsnano.8b0878530830763
   PubMed Web of Science ®Google Scholar
• Heckman KL, DeCoteau W, Estevez A, et al. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain. ACS Nano. 2013;7(12):10582–10596. doi:10.1021/nn403743b24266731
   PubMed Web of Science ®Google Scholar
• Damiani G, Pacifico A, Linder DM, et al. Nanodermatology-based solutions for psoriasis: state-of-the art and future prospects. Dermatol Ther. 2019;32(6):e13113. doi:10.1111/dth.1311331600849
   PubMed Web of Science ®Google Scholar
• DeLouise LA. Applications of Nanotechnology in Dermatology. J Invest Dermatol. 2012;132(3):964–975. doi:10.1038/jid.2011.42522217738
   PubMed Web of Science ®Google Scholar
• Crini G. Review: a history of Cyclodextrins. Chem Rev. 2014;114(21):10940–10975. doi:10.1021/cr500081p25247843
   PubMed Web of Science ®Google Scholar
• Liu K, Jiang X, Hunziker P. Carbohydrate-based amphiphilic nano delivery systems for cancer therapy. Nanoscale. 2016;8(36):16091–16156.27714108
   PubMed Web of Science ®Google Scholar
• Sun T, Wang Q, Bi Y, et al. Supramolecular amphiphiles based on cyclodextrin and hydrophobic drugs. J Mater Chem B. 2017;5(14):2644–2654. doi:10.1039/C6TB03272A32264043
   PubMed Web of Science ®Google Scholar
• Bonnet V, Gervaise C, Djedaïni-Pilard F, Furlan A, Sarazin C. Cyclodextrin nanoassemblies: a promising tool for drug delivery. Drug Discov Today. 2015;20(9):1120–1126. doi:10.1016/j.drudis.2015.05.00826037681
   PubMed Web of Science ®Google Scholar
• Yu N, Hao J, Wang Q, Huang K, Geng B. Self-assembled porous ceria nanostructures with excellent water solubility and antioxidant properties. RSC Adv. 2016;6(51):45957–45962. doi:10.1039/C6RA05630J
   Web of Science ®Google Scholar
• Sun L, Liu Z, Wang L, et al. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel. J Controlled Release. 2017;254:44–54. doi:10.1016/j.jconrel.2017.03.385
   PubMed Web of Science ®Google Scholar
• Ali SS, Hardt JI, Quick KL, et al. A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radical Biol Med. 2004;37(8):1191–1202. doi:10.1016/j.freeradbiomed.2004.07.00215451059
   PubMed Web of Science ®Google Scholar
• Pirmohamed T, Dowding JM, Singh S, et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun. 2010;46(16):2736–2738. doi:10.1039/b922024k
   PubMed Web of Science ®Google Scholar
• Li X-J, Li W-T, Li Z-H-R, et al. Iron-chelated polydopamine decorated doxorubicin-loaded nanodevices for reactive oxygen species enhanced cancer combination therapy. Front Pharmacol. 2019;10:75.30787876
   PubMed Web of Science ®Google Scholar
• Kang N-W, Kim M-H, Sohn S-Y, et al. Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice. Biomaterials. 2018;182:245–258. doi:10.1016/j.biomaterials.2018.08.03030142524
   PubMed Web of Science ®Google Scholar
• Montini T, Melchionna M, Monai M, Fornasiero P. Fundamentals and catalytic applications of CeO2-based materials. Chem Rev. 2016;116(10):5987–6041. doi:10.1021/acs.chemrev.5b0060327120134
   PubMed Web of Science ®Google Scholar
• Xu C, Lin Y, Wang J, et al. Nanoceria-triggered synergetic drug release based on CeO2-capped mesoporous silica host–guest interactions and switchable enzymatic activity and cellular effects of CeO2. Adv Healthc Mater. 2013;2(12):1591–1599. doi:10.1002/adhm.20120046423630084
   PubMed Web of Science ®Google Scholar
• Chen X, Parker SG, Zou G, Su W, Zhang Q. β-Cyclodextrin-functionalized silver nanoparticles for the naked eye detection of aromatic isomers. ACS Nano. 2010;4(11):6387–6394. doi:10.1021/nn101660520973513
   PubMed Web of Science ®Google Scholar
• Song S, Chong Y, Fu H, Ning X, Shen H, Zhang Z. HP-β-CD functionalized Fe3O4/CNPs-based theranostic nanoplatform for ph/nir responsive drug release and mr/nirfl imaging-guided synergetic chemo/photothermal therapy of tumor. ACS Appl Mater Interfaces. 2018;10(40):33867–33878. doi:10.1021/acsami.8b0999930215249
   PubMed Web of Science ®Google Scholar
• Yang B, Chen Y, Shi J. Reactive Oxygen Species (ROS)-Based Nanomedicine. Chem Rev. 2019;119(8):4881–4985. doi:10.1021/acs.chemrev.8b0062630973011
   PubMed Web of Science ®Google Scholar